EMG
ADAP

Ellington Management Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Ellington Management Group’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,000
Closed -$180K – 560
2017
Q3 		$180K Buy
+22,000
New +$180K 0.03% 533